Defective ATM‐p53–mediated apoptotic pathway in multiple sclerosis
Authors:
- 21 September 2005
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 58 (4) , 577-584
Abstract
Defective elimination of autoreactive cells is thought to play a role in the development of autoimmune diseases including multiple sclerosis (MS). We examined the activation of the ATM‐CHK2‐p53 pathway in MS patients after subjecting their peripheral blood mononuclear cells to γ‐irradiation. We found that peripheral blood mononuclear cells from a subset of MS patients show resistance to cell death induced by irradiation. This defect is due to impaired constitutive expression and activation of ATM (ataxia telangiectasia mutated), resulting in impaired stabilization of p53. We predict that these fundamental defects likely alter the regulation of the immune population of cells in MS and may contribute to the development or progression of the disease. Ann Neurol 2005;58:577–584Keywords
This publication has 46 references indexed in Scilit:
- Reduced p53 in peripheral blood mononuclear cells from patients with rheumatoid arthritis is associated with loss of radiation‐induced apoptosisArthritis & Rheumatism, 2005
- Transcription-Based Prediction of Response to IFNβ Using Supervised Computational MethodsPLOS Biology, 2004
- Do we need new treatment principles for RA patients beyond anti-TNFα medication?Autoimmunity Reviews, 2004
- Post-translational modification of p53 in tumorigenesisNature Reviews Cancer, 2004
- Cancer Incidence in Multiple Sclerosis: A 35-Year Follow-UpNeuroepidemiology, 2004
- Boosting p53 with interferon and virusesNature Immunology, 2003
- Role of gene expression microarray analysis in finding complex disease genesGenetic Epidemiology, 2002
- Ionizing radiation activates the ATM kinase throughout the cell cycleOncogene, 2000
- THE GENETIC DEFECT IN ATAXIA-TELANGIECTASIAAnnual Review of Immunology, 1997
- The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivationCell, 1992